Stock VLG VENTURE LIFE GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company Venture Life Group plc

Equities

VLG

GB00BFPM8908

Pharmaceuticals

Market Closed - London S.E.
Other stock markets
 11:35:20 2024-04-26 EDT 		5-day change 1st Jan Change
41.5 GBX -1.78% Intraday chart for Venture Life Group plc +6.41% +23.88%
04-19 Venture Life renews revolving credit facility with Santander and HSBC AN
04-19 Venture Life Group plc Renews Revolving Credit Facility with Santander UK PLC and HSBC Innovation Bank Limited CI

Business Summary

Venture Life Group PLC is a United Kingdom-based consumer self-care company. The principal activities of the Company are the development, manufacturing, and commercialization of healthcare products, including medical devices, food supplements and cosmetics for the ageing population. The Company's product portfolio includes products, such as the UltraDEX and Dentyl oral care product ranges; the Balance Activ range in the area of women's intimate healthcare; the Lift Glucose and Glucogel product ranges for hypoglycaemia; Gelclair, Xonrid, and Pomi-T for oncology support products provide symptomatic relief for some of the side effects associated with cancer and its treatment; the Procto-eze Plus product ranges for hemorrhoids, and other Dermatology products. The Company operates through two segments: Venture Life Brands and Customer Brands. The Company's subsidiaries include Venture Life Limited, Lubatti Limited, Periproducts Limited, HL Healthcare Ltd, and Venture Life Healthcare Ltd.

Number of employees: 153

Sales per Business

GBP in Million2022Weight2023Weight Delta
Venture Life Brands
59.8 %
23 52.6 % 31 59.8 % +32.82%
Customer Brands
40.2 %
21 47.4 % 21 40.2 % -0.78%

Sales per region

GBP in Million2022Weight2023Weight Delta
United Kingdom
37.0 %
20 46.2 % 19 37.0 % -6.38%
Italy
22.2 %
13 29.6 % 11 22.2 % -12.21%
Rest of Europe
18.4 %
3 7.9 % 9 18.4 % +172.33%
Rest of the World
7.9 %
2 3.8 % 4 7.9 % +138.51%
Switzerland
3.2 %
2 4.2 % 2 3.2 % -9.18%
Ireland
2.4 %
1 2.9 % 1 2.4 % -3.62%
Canada
1.9 %
-- 1 1.9 % -
Netherlands
1.8 %
1 3.2 % 1 1.8 % -32.57%
Brazil
1.7 %
-- 1 1.7 % -
Germany
1.2 %
0 1.1 % 1 1.2 % +24.95%
France
1.2 %
-- 1 1.2 % -
United States
1.1 %
0 1.1 % 1 1.1 % +18.24%

Managers

Managers TitleAgeSince
Jeremy Randall FOU
 Founder 60 05-12-11
Daniel Wells DFI
 Director of Finance/CFO 37 21-11-30
Gianluca Braguti BRD
 Director/Board Member - 14-03-23

Members of the board

Members of the board TitleAgeSince
Jeremy Randall FOU
 Founder 60 05-12-11
Mark Adams BRD
 Director/Board Member 60 22-10-09
Gianluca Braguti BRD
 Director/Board Member - 14-03-23
Paul McGreevy CHM
 Chairman 56 22-05-16
Carl Dempsey BRD
 Director/Board Member - 18-09-19
Daniel Wells DFI
 Director of Finance/CFO 37 21-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 126,498,197 105,624,920 ( 83.50 %) 0 83.50 %

Shareholders

NameEquities%Valuation
Slater Investments Ltd.
11.32 %
14,324,372 11.32 % 7 M p
BGF Investment Management Ltd.
9.009 %
11,396,824 9.009 % 5 M p
Hargreaves Lansdown Asset Management Ltd.
8.380 %
10,600,549 8.380 % 5 M p
J.O. Hambro Capital Management Ltd.
8.261 %
10,450,000 8.261 % 5 M p
River Global Investors LLP
7.790 %
9,854,209 7.790 % 5 M p
Close Asset Management Ltd.
7.390 %
9,348,217 7.390 % 4 M p
Stonehage Fleming Investment Management Ltd.
6.710 %
8,488,029 6.710 % 4 M p
Chelverton Asset Management Ltd.
5.558 %
7,030,442 5.558 % 3 M p
Gianluca Braguti
2.959 %
3,742,730 2.959 % 2 M p
Thesis Unit Trust Management Ltd.
2.911 %
3,682,438 2.911 % 2 M p

Company contact information

Venture Life Group Plc

12 The Courtyard Eastern Road

RG12 2XB, Bracknell

+44 13 4457 8004

http://www.venture-life.com
address Venture Life Group plc(VLG)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Venture Life Group plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.415 GBP
Average target price
0.76 GBP
Spread / Average Target
+83.13%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
VENTURE LIFE GROUP PLC Stock Venture Life Group plc
+23.88% 65.39M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VLG Stock
  4. Company Venture Life Group plc